π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This will be a randomized single-blind controlled trial to determine the im...
Status
Completed
Location
Hospital Ampang
Start Date
2022-09-20
Trial ID
NCT05517642
This pilot study will evaluate the feasibility, tolerability, and prelimina...
Status
Not Yet Recruiting
Location
University of Maryland Medical Center, Stoler Infusion Center
Start Date
2026-08-01
Trial ID
NCT07674277
In the planned prospective randomized study, oxidative stress will be inves...
Status
Unknown
Location
Department of Paediatric and Adolescent Surgery
Start Date
2019-10-02
Trial ID
NCT03723642
Treatments Being Tested
This study is being done to learn more about a possible new treatment for p...
Status
Not Yet Recruiting
Location
Children's National Hospital
Start Date
2025-07-25
Trial ID
NCT06989567
Treatments Being Tested
For a newborn, locating and latching onto the mother's breast is the founda...
Status
Not Yet Recruiting
Location
Chu Dijon Bourgogne
Start Date
2026-05
Trial ID
NCT07616076
The aim of the present study is comparing the effectiveness of different tr...
Status
Completed
Location
Faculty of medicine, Beni-suef univeristy - Beni-Seuf university hospital
Start Date
2019-11-01
Trial ID
NCT04301336
This study will investigate the safety, tolerability and potential for the ...
Status
Unknown
Location
Hemorio
Start Date
2016-11
Trial ID
NCT03062501
Treatments Being Tested
Part 1: A pilot study in patients with homozygous S (HbSS) or hemoglobin S ...
Status
Completed
Location
University of Washington
Start Date
2013-03
Trial ID
NCT01800526
Treatments Being Tested
Sickle cell disease (SCD) is a genetic blood disorder. Crizanlizumab is ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-14
Trial ID
NCT04662931
Treatments Being Tested
The purpose of this study is to find out whether siplizumab is safe and eff...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2023-09-28
Trial ID
NCT06078696